Rockefeller Capital Management’s Medpace MEDP Stock Holding History

Rockefeller Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$190K	Sell	395 -35	-8%	-$17.9K	﹤0.01%	2532
2025 Q4	$242K	Sell	430 -345	-45%	-$196K	﹤0.01%	2261
2025 Q3	$398K	Buy	+775	New	+$338K	﹤0.01%	1884
2023 Q1	–	Sell	-143	Closed	-$30K	–	3120
2022 Q4	$30K	Buy	143 +112	+361%	+$22.4K	﹤0.01%	2633
2022 Q3	$4K	Sell	31 -41	-57%	-$6.54K	﹤0.01%	3411
2022 Q2	$10K	Buy	72 +27	+60%	+$3.91K	﹤0.01%	3125
2022 Q1	$7K	Buy	45 +27	+150%	+$4.45K	﹤0.01%	3225
2021 Q4	$3K	Buy	18 +4	+29%	+$838	﹤0.01%	3442
2021 Q3	$2K	Sell	14 -4	-22%	-$730	﹤0.01%	3451
2021 Q2	$3K	Buy	18 +6	+50%	+$1.04K	﹤0.01%	3170
2021 Q1	$1K	Sell	12 -7	-37%	-$1.07K	﹤0.01%	3186
2020 Q4	$2K	Buy	19 +11	+138%	+$1.39K	﹤0.01%	2649
2020 Q3	$0	Buy	+8	New	+$925	﹤0.01%	2699

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Rockefeller Capital Management's MEDP Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Medpace (MEDP) stake by 8.1% in Q1 2026, selling an estimated $17.9K and leaving 395 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #2532.

Rockefeller Capital Management first reported a position in MEDP in Q3 2020 and has held it in 13 quarters since. The position peaked at $398K in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Rockefeller Capital Management held 395 shares of Medpace worth $190K as of Q1 2026.
Rockefeller Capital Management sold 35 Medpace shares in Q1 2026, an estimated $17.9K.
Medpace made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2532 holding.
Rockefeller Capital Management first reported a position in Medpace in Q3 2020 and has held it in 13 quarters since.
Rockefeller Capital Management's Medpace position peaked at $398K in Q3 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.